Senti Biosciences Analyst Ratings
Senti Biosciences Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
01/30/2023 | 348.76% | Chardan Capital | $12 → $8 | Maintains | Buy |
01/27/2023 | 68.28% | Morgan Stanley | $7.5 → $3 | Maintains | Equal-Weight |
12/16/2022 | — | JP Morgan | Initiates Coverage On | → Neutral | |
10/07/2022 | 320.71% | Morgan Stanley | → $7.5 | Initiates Coverage On | → Equal-Weight |
09/29/2022 | 292.66% | B of A Securities | → $7 | Initiates Coverage On | → Buy |
09/23/2022 | 573.14% | Chardan Capital | → $12 | Initiates Coverage On | → Buy |
日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变化 | 上一页/当前额定值 |
---|---|---|---|---|---|
01/30/2023 | 348.76% | 查丹资本 | 12 美元 → 8 美元 | 维护 | 买 |
01/27/2023 | 68.28% | 摩根士丹利 | 7.5 美元 → 3 美元 | 维护 | 重量相等 |
2022 年 12 月 16 日 | — | 摩根大通 | 开启覆盖范围 | → 中立 | |
2022 年 7 月 10 日 | 320.71% | 摩根士丹利 | → 7.5 美元 | 开启覆盖范围 | → 重量相等 |
09/29/2022 | 292.66% | A 证券的 B | → 7 美元 | 开启覆盖范围 | → 购买 |
09/23/2022 | 573.14% | 查丹资本 | → 12 美元 | 开启覆盖范围 | → 购买 |
What is the target price for Senti Biosciences (SNTI)?
Senti Biosciences(SNTI)的目标价格是多少?
The latest price target for Senti Biosciences (NASDAQ: SNTI) was reported by Morgan Stanley on January 27, 2023. The analyst firm set a price target for $3.00 expecting SNTI to rise to within 12 months (a possible 68.28% upside). 5 analyst firms have reported ratings in the last year.
摩根士丹利于2023年1月27日公布了Senti Biosciences(纳斯达克股票代码:SNTI)的最新目标股价。这家分析公司将目标价定为3.00美元,预计SNTI将在12个月内升至68.28%(可能上涨68.28%)。去年,有5家分析公司公布了评级。
What is the most recent analyst rating for Senti Biosciences (SNTI)?
Senti Biosciences(SNTI)的最新分析师评级是多少?
The latest analyst rating for Senti Biosciences (NASDAQ: SNTI) was provided by Morgan Stanley, and Senti Biosciences maintained their equal-weight rating.
Senti Biosciences(纳斯达克股票代码:SNTI)的最新分析师评级由摩根士丹利提供,Senti Biosciences维持了同等权重评级。
When is the next analyst rating going to be posted or updated for Senti Biosciences (SNTI)?
Senti Biosciences(SNTI)的下一个分析师评级将在何时公布或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Senti Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Senti Biosciences was filed on January 27, 2023 so you should expect the next rating to be made available sometime around January 27, 2024.
分析师在进行了广泛的研究后得出了股票评级,包括浏览公开财务报表,与Senti Biosciences的高管和客户交谈,以及听取财报电话会议。大多数分析师每三个月这样做一次,因此每家公司每年应该获得4次评级。Senti Biosciences的最新评级是在2023年1月27日公布的,因此你应该预计下一个评级将在2024年1月27日左右公布。
Is the Analyst Rating Senti Biosciences (SNTI) correct?
分析师对Senti Biosciences(SNTI)的评级是否正确?
While ratings are subjective and will change, the latest Senti Biosciences (SNTI) rating was a maintained with a price target of $7.50 to $3.00. The current price Senti Biosciences (SNTI) is trading at is $1.78, which is out of the analyst's predicted range.
尽管评级是主观的,并且会发生变化,但最新的Senti Biosciences(SNTI)评级保持不变,目标价为7.50美元至3.00美元。Senti Biosciences(SNTI)目前的交易价格为1.78美元,超出了分析师的预期区间。